Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $61.11
- 52-wk low
- $34.15
- Prev close
- $48.13
- Mkt cap
- $202.13B
- P/E
- 11.1x
- Fwd P/E
- 13.2x
Smart money
Earnings
Earnings came in 17.1% above what analysts expected.
Financials
Is the business strong?
Fairly priced and profitable.
- Net margin
- 35.3%
- P/E
- 11.09
- Forward P/E
- 13.23
- Market cap
- $202.1B
Valuation
- P/S0.61
- P/B5.81
- Dividend yield4.0%
Quality
Technicals
Price structure
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Novo Nordisk commences study for reduced Wegovy pill dosing
NeutralAug 20Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills
Leans bullishAug 19Novo Nordisk Begins New Study Testing Smaller Doses Of Blockbuster Wegovy – A Look At Some Key Highlights
Leans bullishAug 19